CHIMIRRI, Alba
 Distribuzione geografica
Continente #
NA - Nord America 8.144
EU - Europa 6.949
AS - Asia 1.623
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 7
OC - Oceania 6
AF - Africa 4
Totale 16.742
Nazione #
US - Stati Uniti d'America 8.106
IE - Irlanda 2.114
SE - Svezia 1.540
UA - Ucraina 1.092
CN - Cina 992
DE - Germania 650
VN - Vietnam 506
GB - Regno Unito 369
FI - Finlandia 368
IT - Italia 316
BE - Belgio 268
IN - India 76
RU - Federazione Russa 71
AT - Austria 63
CA - Canada 36
FR - Francia 35
IR - Iran 24
CZ - Repubblica Ceca 11
PL - Polonia 9
NL - Olanda 8
A2 - ???statistics.table.value.countryCode.A2??? 6
CH - Svizzera 6
BG - Bulgaria 5
IL - Israele 4
JP - Giappone 4
KR - Corea 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
CL - Cile 3
EG - Egitto 3
ES - Italia 3
EU - Europa 3
PE - Perù 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
HU - Ungheria 2
LU - Lussemburgo 2
RO - Romania 2
SG - Singapore 2
TR - Turchia 2
AL - Albania 1
BR - Brasile 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
IS - Islanda 1
KZ - Kazakistan 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
Totale 16.742
Città #
Dublin 2.112
Jacksonville 2.073
Chandler 1.403
Nyköping 1.010
Dong Ket 505
Beijing 473
Ashburn 444
Cambridge 357
Princeton 354
Dearborn 333
Medford 300
Des Moines 270
Brussels 265
Boardman 232
Ann Arbor 150
Lancaster 130
Woodbridge 110
Wilmington 96
Jinan 72
San Mateo 68
Nanjing 65
Vienna 61
Pune 54
Messina 50
Shenyang 48
Haikou 39
Milan 33
Hebei 31
Zhengzhou 30
Houston 26
Ningbo 26
Seattle 26
Catania 25
Saint Petersburg 22
Taizhou 21
Tianjin 21
Fuzhou 20
Hangzhou 20
New York 20
Washington 20
Ardabil 19
Norwalk 19
Augusta 18
Nanchang 17
Ottawa 17
Leawood 15
Monmouth Junction 15
Taiyuan 14
Changsha 12
Jiaxing 12
Auburn Hills 11
Brno 11
Edinburgh 11
Guangzhou 11
London 11
Hanover 10
Los Angeles 9
Clearwater 8
Lappeenranta 8
Montréal 8
Brooklyn 7
Hefei 7
Helsinki 7
Kunming 7
Warsaw 7
Chicago 6
Mcallen 6
Nicotera 6
Novokuznetsk 6
Riva 6
Rome 6
Amsterdam 5
Bremen 5
Dallas 5
Seelze 5
Sofia 5
Toronto 5
Auckland 4
Bangalore 4
Catanzaro 4
Florence 4
Mumbai 4
Munich 4
Nanning 4
Phoenix 4
Saint Louis 4
Tappahannock 4
Amelia 3
Brugherio 3
Como 3
Cormeilles-en-Parisis 3
Falls Church 3
Ferrara 3
Frankfurt am Main 3
Frigento 3
Kemerovo 3
Lanzhou 3
Las Vegas 3
Lima 3
Manchester 3
Totale 11.851
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 194
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 153
1-Aryl-1H,3H-thiazolo[3,4-a]benzimidazole derivatives 153
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 149
1,3-Thiazolidin-4-ones: potent and selective anti-HIV-1 agents 148
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 144
1-fluoromethyl-1-methyl-1H,3H-thiazolo-[3,4-a]benzimidazole 143
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 132
AMPA receptor antagonists: Synthesis and pharmacological evaluation 91
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 89
Nuovi Antagonisti Noncompetitivi del Recettore AMPA a struttura tetraidroisochinolinica, 88
Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice 79
Nuovi Antagonisti Non-Competitivi Del Recettore NMDA/NR2b: Design e Sintesi” 77
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 77
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 76
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 75
Sintesi e SAR di nuovi inibitori dell'acetilcolinesterasi come potenziali agenti anti-Alzheimer 74
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 73
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 72
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 72
Anti-HIV agents: design and discovery of new potent RT inhibitors 70
3-[2-(1H-1,3-benzodiazol-2-yl)ethyl]1,3-oxazolidin-2-one 69
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 68
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 68
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 68
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 67
Binding modes of noncompetitive AMPA antagonists: a computational approach 66
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 66
Annelated 1,5-benzothiazepines 66
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 65
7,11b-dihydro-9,10-dimethoxy-3,11b- diphenyl[1,2,4]oxadiazolo[5,4-a]-[2,3]benzodiazepin-6(5H)-one 65
Design and synthesis of acetylcholinesterase inhibitors 65
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 65
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 65
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 65
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 64
Inhibitors of the Interactions between HIV-1 IN and the Cofactor LEDGF/p75 64
Progettazione Sintesi e SAR di nuovi derivati tetraidroisochinolinici. 63
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 63
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 63
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 63
Azirino[1,2-d][1,4]benzodiazepine derivatives and related 1,4- benzodiazepines as anticonvulsant agents in DBA/2 mice 63
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 62
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 62
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 62
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 62
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors. 61
Binding mode prediction of Strand Transfer HIV-1 Integrase Inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 Integrase 61
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 61
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 61
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation 61
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 60
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 60
High-performance liquid chromatographic determination of new 2,3-benzodiazepines 60
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 60
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 60
Antiretroviral strategy using multi-target agents 60
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 60
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 60
Synthesis and pharmacological evaluation of new tetrahydroisoquinoline derivatives. 59
AMPA Receptor Antagonists as Potential Anticonvulsant Drugs 59
Synthesis and anticonvulsant activity of triazolo[4,5-c][2,3]benzodiazepines 59
Electronic and conformational properties of 2,3-benzodiazepine derivatives 59
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 59
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 59
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 59
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 58
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 58
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 58
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 58
Antagonisti non-competitivi del recettore AMPA: progettazione, sintesi, SAR e studio del profilo farmacocinetico 58
Successful optimization of human carbonic anhydrase inhibitors as neuroprotective agents 58
NOVEL ANNELATED 1,4-BENZODIAZEPINES AND 1,5-BENZODIAZEPINES 57
Design e sintesi di nuovi Antagonisti Noncompetitivi del Recettore AMPA 57
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 57
Efficient 3D Database screening for novel HIV-1 IN inhibitors 57
Sviluppo di modello farmacoforico predittivo per gli NR2B antagonisti del recettore NMDA 57
Searching for NR2B/NMDA Receptor Antagonists As Neuroprotective Agents 57
HIV-1 integrase strand-transfer inhibitors: design and synthetic strategies in the process of a lead optimization 57
2-Hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: Influence of the alkylation of position 4 57
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 57
QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor 57
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 56
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 56
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 56
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 55
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitor 55
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 55
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 55
Combined ligand-based and target-based approach to design NR2B/NMDA receptor antagonists 55
Pyrrolo[1',2':1,2]imidazo[4,5-b]pyridines, pyrrolo[2',1':2,3]imidazo[4,5-c]pyridines and pyrrolo[2,1-f]purines as potential benzodiazepine receptor ligands. 55
Discovery of potent HIV-1 integrase strand transfer inhibitors: design and synthetic strategies 55
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 55
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 55
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 54
Synthesis and pharmacological evaluation of 4-aryl-6,7- dimethoxyphthalazines as anticonvulsant agents 54
Synthesis, structural features and anti-HIV activity of TBZ analogues 54
Sviluppo del modello DNA-integrasi dell'HIV-1: studi di docking e di dinamica molecolare 54
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 54
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 54
Totale 6.951
Categoria #
all - tutte 53.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.464


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201943 0 0 0 0 0 0 0 0 10 9 7 17
2019/20203.066 631 277 8 261 10 319 407 341 35 314 455 8
2020/20212.634 326 3 432 89 51 310 8 277 5 276 235 622
2021/20221.911 22 339 48 59 108 9 132 76 37 25 367 689
2022/20236.017 471 420 263 419 502 616 123 352 2.554 21 226 50
2023/20241.309 116 224 102 416 153 208 24 64 2 0 0 0
Totale 16.922